Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Jacob Schuringa

Showing results (121-130 of 146) with videos related to

Pageof 15
Sort By:
Cell Reports|January 11, 2016
Non-canonical PRC1.1 Targets Active Genes Independent of H3K27me3 and Is Essential for LeukemogenesisVincent van den Boom, Henny Maat, Marjan Geugien, et al.
Elife|September 2, 2022
Crosstalk between AML and stromal cells triggers acetate secretion through the metabolic rewiring of stromal cellsNuria Vilaplana-Lopera, Vincent Cuminetti, Ruba Almaghrabi, et al.
Nature Communications|March 2, 2022
The Glycolytic Gatekeeper PDK1 defines different metabolic states between genetically distinct subtypes of human acute myeloid leukemiaAyşegül Erdem, Silvia Marin, Diego A Pereira-Martins, et al.
European Journal of Pharmacology|April 17, 2026
Quizartinib-induced resistance drives clonal emergence of MV4-11 cells with molecular alterations enabling multidrug antileukemic escapeLivia Bassani Lins de Miranda, Keli Lima, Diego A Pereira-Martins, et al.
Iscience|June 11, 2021
The USP7-TRIM27 axis mediates non-canonical PRC1.1 function and is a druggable target in leukemiaHenny Maat, Tjerk Jan Atsma, Shanna M Hogeling, et al.
Blood|October 14, 2016
Establishing human leukemia xenograft mouse models by implanting human bone marrow-like scaffold-based nichesAntonella Antonelli, Willy A Noort, Jenny Jaques, et al.
Science Advances|April 14, 2023
M2 macrophages drive leukemic transformation by imposing resistance to phagocytosis and improving mitochondrial metabolismIsabel Weinhäuser, Diego A Pereira-Martins, Luciana Y Almeida, et al.
Nature Reviews. Cancer|October 12, 2012
Cancer stem cell definitions and terminology: the devil is in the detailsPeter Valent, Dominique Bonnet, Ruggero De Maria, et al.
European Journal of Pharmacology|June 8, 2024
Potency and efficacy of pharmacological PIP4K2 inhibitors in acute lymphoblastic leukemiaKeli Lima, Frederico Lisboa Nogueira, Marcella Cipelli, et al.
Cancer Cell|September 25, 2018
Prospective Isolation and Characterization of Genetically and Functionally Distinct AML SubclonesBauke de Boer, Janine Prick, Maurien G Pruis, et al.
Pageof 15

Showing results (121-130 of 146) with videos related to

Sort By:
Pageof 15
Cell Reports|January 11, 2016
Non-canonical PRC1.1 Targets Active Genes Independent of H3K27me3 and Is Essential for LeukemogenesisVincent van den Boom, Henny Maat, Marjan Geugien, et al.
Elife|September 2, 2022
Crosstalk between AML and stromal cells triggers acetate secretion through the metabolic rewiring of stromal cellsNuria Vilaplana-Lopera, Vincent Cuminetti, Ruba Almaghrabi, et al.
Nature Communications|March 2, 2022
The Glycolytic Gatekeeper PDK1 defines different metabolic states between genetically distinct subtypes of human acute myeloid leukemiaAyşegül Erdem, Silvia Marin, Diego A Pereira-Martins, et al.
European Journal of Pharmacology|April 17, 2026
Quizartinib-induced resistance drives clonal emergence of MV4-11 cells with molecular alterations enabling multidrug antileukemic escapeLivia Bassani Lins de Miranda, Keli Lima, Diego A Pereira-Martins, et al.
Iscience|June 11, 2021
The USP7-TRIM27 axis mediates non-canonical PRC1.1 function and is a druggable target in leukemiaHenny Maat, Tjerk Jan Atsma, Shanna M Hogeling, et al.
Blood|October 14, 2016
Establishing human leukemia xenograft mouse models by implanting human bone marrow-like scaffold-based nichesAntonella Antonelli, Willy A Noort, Jenny Jaques, et al.
Science Advances|April 14, 2023
M2 macrophages drive leukemic transformation by imposing resistance to phagocytosis and improving mitochondrial metabolismIsabel Weinhäuser, Diego A Pereira-Martins, Luciana Y Almeida, et al.
Nature Reviews. Cancer|October 12, 2012
Cancer stem cell definitions and terminology: the devil is in the detailsPeter Valent, Dominique Bonnet, Ruggero De Maria, et al.
European Journal of Pharmacology|June 8, 2024
Potency and efficacy of pharmacological PIP4K2 inhibitors in acute lymphoblastic leukemiaKeli Lima, Frederico Lisboa Nogueira, Marcella Cipelli, et al.
Cancer Cell|September 25, 2018
Prospective Isolation and Characterization of Genetically and Functionally Distinct AML SubclonesBauke de Boer, Janine Prick, Maurien G Pruis, et al.
Pageof 15